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Summary
Despite there being numerous studies of intraoperative graft flow assessment by transit-time flow measurement (TTFM) on outcomes after
coronary artery bypass grafting (CABG), the adoption of contemporary TTFM is low. Therefore, on 31 January 2018, a systematic literature
search was performed to identify articles that reported (i) the amount of grafts classified as abnormal or which were revised or (ii) an asso-
ciation between TTFM and outcomes during follow-up. Random-effects models were used to create pooled estimates with 95% confi-
dence intervals (CI) of (i) the rate of graft revision per patient, (ii) the rate of graft revision per graft and (iii) the rate of graft revision among
grafts deemed abnormal based on TTFM parameters. The search yielded 242 articles, and 66 original articles were included in the system-
atic review. Of those articles, 35 studies reported on abnormal grafts or graft revisions (8943 patients, 15 673 grafts) and were included in
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the meta-analysis. In 4.3% of patients (95% CI 3.3–5.7%, I2 = 73.9) a revision was required and 2.0% of grafts (95% CI 1.5–2.5%; I2= 66.0)
were revised. The pooled rate of graft revisions among abnormal grafts was 25.1% (95% CI 15.5–37.9%; I2= 80.2). Studies reported sensitiv-
ity ranging from 0.250 to 0.457 and the specificity from 0.939 to 0.984. Reported negative predictive values ranged from 0.719 to 0.980
and reported positive predictive values ranged from 0.100 to 0.840. This systematic review and meta-analysis showed that TTFM could
improve CABG procedures. However, due to heterogeneous data, drawing uniform conclusions appeared challenging. Future studies
should focus on determining the optimal use of TTFM and assessing its diagnostic accuracy.
Keywords: Coronary artery bypass • Intraoperative quality control • Transit time • Transit-time flow measurement • Intraoperative graft
flow assessment • Coronary artery bypass grafting
INTRODUCTION
Outcomes of coronary artery bypass grafting (CABG) have signifi-
cantly improved over the first 50 years since the introduction of
the modern CABG procedure [1]. Despite increasing use of percu-
taneous coronary intervention (PCI), CABG remains the treatment
of choice for patients with complex multivessel disease [2]. While
outcomes of PCI are continuously improving with new advance-
ments, many new techniques to optimize short- and long-term
outcomes of CABG have not been adopted widely [3].
One of such techniques to improve CABG outcomes and graft
patency is intraoperative graft flow assessment. Early graft failure
can occur due to limited outflow, graft kinking upon chest clos-
ure, thrombosis, yet also due to anastomotic problems. A meta-
analysis reported a graft failure rate of 5% and 25% at 3 and
12 months, respectively [4]. Fabricius et al. [5] reported that 23 of
2052 patients (1.1%) who underwent CABG had severely com-
promised haemodynamics due to postoperative myocardial in-
farction (MI). In 21.7% of patients, the cause of this adverse event
was found to be an incorrect anastomosis. Intraoperative graft
assessment has therefore been introduced to identify anastomot-
ic problems and limited outflow before chest closure.
Multiple techniques for intraoperative graft assessment have
been proposed: coronary angiography (CAG), transit-time flow
measurement (TTFM), high-resolution-epicardial ultrasonography
(HR-ECUS) and intraoperative fluorescence imaging (IFI) [6].
Although angiography is thought to be the best and most reliable
method for assessing flow, the infrastructure required for CAG is
rarely available in standard operating theatres. Therefore, the
most adopted strategy to assess graft functioning is TTFM.
Several studies reported associations between TTFM parameters
and the necessity for graft revisions as well as with short- and
medium-term outcomes after CABG; however, results vary con-
siderably [7, 8]. A summary of the evidence could provide
more incentive to adopt TTFM, especially as TTFM has been
criticized [9].
We performed a systematic review and meta-analysis to evalu-
ate the value of TTFM during CABG by determining (i) the rate of
abnormal grafts and graft revisions required when using TTFM
and (ii) the impact of TTFM parameters on angiographic and
clinical outcomes.
METHODS
Search strategy
On 31 January 2018, a systematic literature search in the
PubMed database was performed according to the Preferred
Reporting Items for Systematic reviews and Meta-Analyses
(PRISMA) guideline (Supplementary Materials) to identify
full-length, English-language articles with the following search
term: ‘(transit time OR transit-time) AND coronary artery bypass’.
Studies with the following criteria were included: (i) graft assess-
ment was performed using TTFM; (ii) subjects were adult patients
undergoing CABG; and (iii) it was reported how many grafts had
abnormal TTFM parameters or were revised, or an association
between TTFM parameters and outcomes during follow-up was
investigated.
Titles and abstracts were then screened for inclusion. When
eligible, full-text articles were reviewed (D.J.F.M.T. and S.J.H.).
Only original articles, articles in English, studying humans and
studying TTFM in CABG procedures were considered for inclu-
sion. If multiple articles described the same patient population,
only the article with the largest number of patients or the most
relevant information was included.
Data extraction
The following study characteristics were extracted: prospective ver-
sus retrospective study, the year of publication, the authors and
the number of patients. Furthermore, the following data on surgi-
cal characteristics and TTFM parameters were obtained from each
study: surgical procedure (on-pump or off-pump), which grafts
were used (e.g. internal thoracic artery, great saphenous vein, ra-
dial artery and gastroepiploic artery), the number of grafts assessed
with TTFM, the number of grafts deemed abnormal based on
intraoperative TTFM parameters, the number of grafts that were
revised based on intraoperative TTFM parameters, the reasons
why grafts were deemed ‘abnormal’ or ‘required revision’ based on
intraoperative TTFM parameters [mean graft flow (MGF), pulsatility
index (PI), diastolic filling % (DF%) and percentage of backflow
(%BF) (e.g. insufficiency percentage)] and fast Fourier transform-
ation (FFT). Sensitivity, specificity, negative predictive values (NPV)
and positive predictive values (PPV) were extracted to assess the
diagnostic accuracy of TTFM. Postoperative short-term outcomes
(e.g. till 30 days) and outcomes during follow-up (e.g. beyond
30 days) that were extracted consisted of major adverse cardiac
and cerebrovascular events (MACCE), mortality, MI, postoperative
cardiac enzyme release, stroke, requirement for intra-aortic bal-
loon pump placement, angina and graft failure.
Statistical analyses
The quality of the included studies used in the meta-analysis was
assessed according to the Newcastle-Ottawa-Scale (NOS) [10].
Random-effects models were generated to estimate pooled study
outcomes with 95% confidence intervals (95% CI) of (i) the pro-
portion of revised grafts compared to the total number of
patients studied by TTFM, (ii) the proportion of revised grafts
compared to the total number of grafts on which TTFM was
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applied and (iii) the proportion of revised grafts compared to the
total number of abnormal grafts found by TTFM. For studies that
reported zero events (e.g. no abnormal or revised grafts), 0.1
events were used to calculate an estimated event rate with 95%
CI. The I2 statistic was used to describe the proportion of vari-
ation across studies based on heterogeneity, where low values re-
late to homogeneity (range 0–100). Statistical analyses were
executed with Comprehensive Meta-Analysis software Version
3.3 (Biostat, Englewood, NJ, USA).
RESULTS
Study selection
This systematic review included 66 studies (Fig. 1). In total, 35
unique studies reported on abnormal grafts or graft revisions
with 8943 CABG patients and 15 673 grafts (Table 1) and were
included in the meta-analysis. An overview of the NOS quality as-
sessment is presented in the Supplementary Material, Table S1.
Eight studies reported on the diagnostic accuracy of TTFM
(Supplementary Material, Table S2). Forty-two studies reported
graft patency and clinical outcomes related to TTFM assessments
(Supplementary Material, Tables S3 and S4).
Meta-analysis: abnormal grafts and graft revisions
Individual studies classified grafts as abnormal based either on
low MGF (arterial grafts: <15 ml/min and venous grafts: <20 ml/
min), an increased PI >_5 for both venous and arterial grafts, or
decreased diastolic filling % (<50%). Overall reasons to revise
abnormal grafts were due to kinking or twisting of a graft, graft
or coronary dissection or anastomotic stenosis/thrombosis.
In 25 studies (n = 6488), the pooled rate of graft revisions was
4.3% when estimated per patient (95% CI 3.3–5.7%; I2= 73.9), and
2.0% (95% CI 1.5–2.5%; I2= 66.0) in 23 studies with 12 662 grafts
when estimated per graft (Fig. 2). The pooled rate of graft revision
among abnormal classified grafts was 25.1% (95% CI 15.5–37.9%;
I2= 80.2) among 10 studies that reported both the number of ab-
normal grafts and graft revisions. Main reasons for not revising
abnormal classified grafts were (i) no suspicion on graft failure
after careful surgical inspection or (ii) no better alternative due to
bad quality of the native coronary arteries.
Diagnostic accuracy
Sensitivity rates, describing the accuracy of TTFM, ranged from
0.250 to 0.457 (Supplementary Material, Table S2). Specificity varied
between 0.941 and 0.984 [14, 17, 30]. The probability of having ad-
equate TTFM values with an open graft (e.g. NPV) ranged from
0.719 to 0.980. The probability of having abnormal TTFM values
with failing graft (e.g. PPV) varied from 0.100 to 0.840 [14, 17, 30].
These NPV and PPV values were based on the outcomes of angiog-
raphy performed intraoperatively or on the 4th postoperative day.
Graft patency outcomes
Thirty-two studies evaluated graft patency according to TTFM val-
ues, summarized in Supplementary Material, Table S3 [7, 12, 14–17,
30, 38, 44–68]. Currently, only one small, randomized clinical trial
assigned patients to undergo isolated CABG with or without TTFM
and/or IFI [69]. The Graft Imaging to Improve Patency (GRIIP) study
randomized 156 patients and performed a follow-up CAG at 1 year.
No differences were found in the rate of graft occlusion on CAG
(30.9% vs 28.9%, imaging vs control, respectively, P= 0.82) [69].
Several observational studies reported that abnormal TTFM param-
eters predicted graft failure at 6 months to 1 year [7, 54, 70]. One
study reported no predictive correlation between TTFM parameters
and angiographic graft stenosis at 3 and 12 months [65].
Studies reporting on TTFM cut-off values which predict graft
patency found that predictors of early graft failure were a PI
>5.85 and MGF <20 ml/min for venous grafts, and an MGF of
<11.5 ml/min for arterial grafts [15, 46]. Lehnert et al. [45] found
internal thoracic artery graft patency at 1 year to be significantly
worse when MGF <20 ml/min and worsening with 4% failure
with every 1 ml/min decrease in MGF [odds ratio (OR) 0.96, 95%
CI 0.93–0.99; P = 0.005]. Une et al. [71] reported that a higher
MGF was an independent predictor of great saphenous vein fail-
ure at 1-year follow-up (OR 0.95, 95% CI 0.91–0.99), with an opti-
mal cut-off value of 31 ml/min. The NPV on intermediate-term
graft patency (156 days) in relation to abnormal TTFM values was
0.890 (Supplementary Material, Table S2) [59]. Follow-up on ven-
ous graft patency at 3 years showed that MGF was significantly
higher among patent grafts versus failing grafts (41.3 ± 22.9 ml/
min vs 29.6 ± 18.7 ml/min, respectively; P = 0.01) [55].
Short-term clinical outcomes
Twelve studies evaluated short-term outcomes in relation
with TTFM parameters (Supplementary Material, Table S4)
[8, 13, 25, 27, 54, 62, 69, 71–75]. Bauer et al. [75] compared CABG
Figure 1: Flow chart of the systematic review process. Studies not written in
English, not studying humans, reporting on the same patient population,
reporting on transit-time flow measurement in other procedures besides CABG
and case reports or reviews were excluded. In total, 66 studies were included,
of which 35 studies were incorporated in the meta-analysis. CABG: coronary
artery bypass grafting.
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Figure 2: Random-effects models on pooled TTFM study outcomes. (A) Graft revision per total amount of patients studied by TTFM, (B) graft revisions per total
amount of grafts studied by TTFM and (C) graft revisions per total amount of grafts qualified as abnormal by TTFM. I2 indicates heterogeneity (range 0–100; 0 being
entirely homogenous). CI: confidence intervals; TTFM: transit-time flow measurement.
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with TTFM versus without TTFM and found an increased rate of
intraoperative redo-anastomoses, which coincided with signifi-
cantly lower incidences of ventricular fibrillation, perioperative
MI and postoperative mortality when TTFM was performed.
Furthermore, another study found that CABG with TTFM resulted
in lower rates of postoperative mortality (0% vs 4%), MI (0% vs
5%), intra-aortic balloon pump placement (1% vs 7%) and overall
morbidity (6% vs 16%, all P < 0.05) [27]. Jokinen et al. [54] did not
confirm the predictive capability of TTFM for these outcomes.
Studies that assessed TTFM cut-off values demonstrated that a
PI >5, in arterial and venous grafts, was an independent predictor
of early (30 days) major adverse cardiac events with an OR rang-
ing from 1.8 (95% CI 1.1–2.7, P = 0.0097) [25] to 4.23 (95% CI
1.69–10.59, P = 0.002) [8]. Yet, these abnormal TTFM values did
not predict mid-term mortality or hospital readmission [25].
A study which evaluated off-pump versus on-pump CABG
found lower overall TTFM values to be associated with an
increased incidence of low cardiac output syndrome (P = 0.049).
Off-pump surgery was not associated with higher PI or lower dia-
stolic filling %, and no differences were found in 30-day mortality
and MI between patients who underwent off-pump versus on-
pump CABG [72]. One study reported higher MGF and lower PI in
off-pump procedures [62], while another study showed no differ-
ences in TTFM parameters between on-pump and off-pump [52].
Clinical outcomes during follow-up
The GRIPP trial found no differences in the composite of death, MI
and repeat revascularization at 1 year in patients who underwent
CABG with intraoperative graft flow assessment versus those with-
out intraoperative graft flow assessment (7.7% vs 7.7%, respective-
ly) [69]. However, observational studies showed the positive
predictive capability of TTFM on intermediate-term clinical out-
comes, such as major adverse cardiac events, mortality, intra-aortic
balloon pump placement or cardiac enzyme release [8, 75]. Other
studies reported data that showed no correlation between TTFM
parameters and mid-term hospital readmission (during 1.8-year
follow-up) [25], survival after 3.8 years [74] or even long-term sur-
vival (7.8 ± 0.2 years, Supplementary Material, Table S4) [13].
DISCUSSION
This systematic review and meta-analysis provides an overview of
the literature on intraoperative graft flow assessment by TTFM. We
found that 4.3% of patients undergoing CABG required graft revi-
sions based on TTFM parameters. However, of all grafts that were
classified as abnormal, only 25% of grafts were revised. The sur-
geons’ clinical interpretation of the graft and the quality of the
anastomosis in respect to the quality of the native coronary system
was the main reason for not revising all these grafts. Indeed, the
reported sensitivity of TTFM was fairly low, ranging from 0.250 to
0.457 with TTFM reported specificity varying from 0.941 to 0.984.
Nevertheless, abnormal TTFM parameters were associated with
postoperative mortality and MI, and showed to be of particular
importance in predicting graft patency during follow-up.
Intraoperative graft flow assessment is currently most fre-
quently performed by TTFM, as it performs well compared to
other methods of intraoperative graft quality assessment, such as
thermal CAG, IFI or CAG. Although IFI is associated with higher
sensitivity and specificity compared to TTFM [30], major limita-
tions of IFI consist of not being able to visualize the entire graft
at once and the need to reposition the heart for the laser camera
to capture the immunofluorescent flow, possibly compromising
natural blood flow. While intraoperative CAG would be ideal to
assess graft patency and anastomotic quality, this strategy
requires a ‘hybrid’ operating theatre that is not common in all
institutions.
In this meta-analysis, we found that graft revisions were
required in 2.0% of grafts and in 4.3% of patients undergoing
CABG. Compared to other intraoperative complication rates,
such as stroke at 1.1%, this provides the ability to significantly im-
prove short-term outcomes, considering that TTFM usage led to
graft revision and may have prevented a perioperative MI or
increased cardiac enzyme release which is associated with
impaired long-term outcomes [76].
So far, no randomized controlled trial focusing exclusively on
CABG with TTFM versus without TTFM has been published. Only
one small randomized controlled trial primarily studied IFI in
combination with TTFM (n = 78) versus without intraoperative
graft assessment (n = 78) [69]. No differences existed in intraoper-
ative graft revisions, perioperative adverse events, 1-year graft
patency or clinical outcomes. However, only 1.7% of the grafts
were studied with TTFM exclusively, and thus, the study provides
limited information on the actual impact of TTFM. Larger trials
evaluating the benefit of routinely performing TTFM on early and
late clinical outcomes are warranted.
Observational study data on the impact of TTFM are essential
before randomized data will be available. So far, numerous stud-
ies reported improved outcomes in patients undergoing CABG
with TTFM and only a few reporting no association between
TTFM and postoperative outcomes. However, a great diversity in
different TTFM cut-off values and methods exists. Studies used in
our meta-analysis applied different methods of performing
TTFM, including varying surgical and clinical scenarios, such as
on-pump or off-pump procedures, varying haemodynamics,
venous versus arterial grafts, different locations and number of
coronary stenosis or using single versus sequential anastomoses.
All of these factors have a major influence on coronary flow and
thereby on TTFM parameters. Furthermore, reasons for surgeons
not to revise a graft despite abnormal TTFM parameters were
that after inspecting the anastomosis, no suspicion of an anasto-
motic problem or graft failure was raised, or that there was no
better surgical alternative due to poor native coronary arteries.
Lacking standardized methods of performing and interpreting
TTFM parameters, in combination with non-existent standar-
dized TTFM cut-off values, still introduces a subjective aspect to
TTFM and whether a graft should be revised. The heterogeneity
of study methods and study outcomes could have contributed to
the varying results on the diagnostic accuracy of TTFM
(Supplementary Material, Table S2). This may also have contrib-
uted to the statistical heterogeneity (I2 >_ 66).
The strength of TTFM is that it is able to detect truly failing and
truly patent grafts (true positives and true negatives, respectively).
False positives (e.g. patent graft with high PI) rarely occur; how-
ever, difficulties exist in detecting poor grafts with a low PI or
high MGF (false negatives), which could lead to unnecessary graft
revisions [14]. Therefore, it remains challenging to interpret TTFM
results and translate it into decision-making during each CABG
procedure. Di Giammarco et al. [77] showed that the diagnostic
accuracy of TTFM increased to 100% NPV and 100% PPV when it
was combined with HR-ECUS. Adding HR-ECUS to TTFM thereby
overcomes the relatively modest diagnostic accuracy of TTFM
alone. By including HR-ECUS to the surgeon’s appraisal of graft
660 D.J.F.M. Thuijs et al. / European Journal of Cardio-Thoracic Surgery
D
ow
nloaded from
 https://academ
ic.oup.com
/ejcts/article-abstract/56/4/654/5419275 by Erasm
us U
niversity R
otterdam
 user on 28 N
ovem
ber 2019
and anastomotic quality, in relation to native coronary targets
and run-off, the best surgical and clinical outcomes for patients
undergoing CABG could be ensured. Besides, HR-ECUS with
TTFM could provide beneficial insights for young surgeons to fur-
ther improve their surgical techniques.
Standardization on how to perform TTFM, what TTFM values
to expect for specific grafts and anastomoses and which cut-offs
to use for graft revision are essential to increase the use of TTFM
amongst surgeons. Moreover, the studies included in current
meta-analysis are of moderate quality, according to the NOS cri-
teria. Surgeons may not be therefore convinced to use TTFM.
The prospective, multicentre REQUEST registry collected infor-
mation on standardized TTFM and ultrasound assessments in
patients undergoing CABG (n = 1046, ClincalTrials.gov:
NCT02385344). This registry could provide crucial information
on how to incorporate TTFM in daily clinical practice by provid-
ing insights into whether TTFM is effective and improves out-
comes in patients undergoing CABG. Furthermore, it could
quantify potential benefits of combining HR-ECUS with TTFM on
graft and anastomosis quality assessment.
Finally, a clinical issue that remains is that long-term graft fail-
ure may still occur as a result of other mechanisms than those
controlled by TTFM. This could be one of the reasons why sur-
geons doubt its clinical impact and consequently why routine
use of TTFM has been limited. Other factors that potentially influ-
ence the adoption rate of intraoperative quality assessment are
(i) adequately interpreting and acting upon TTFM determinants
come with a learning curve, (ii) the time of the procedure might
increase (e.g. depending on the need to revise a graft) and (iii)
concerns might remain of needlessly revising a patent graft (e.g.
due to limited diagnostic accuracy of TTFM alone) [17, 78].
Furthermore, no high-quality data on the impact of TTFM on sur-
gical and clinical outcomes after CABG exist that could influence
the adoption rate of TTFM by individual surgeons. Nevertheless,
this systematic review does show that TTFM provides valuable
intraoperative data on graft and anastomotic quality, which could
contribute to improved surgical and clinical outcomes. Despite
potential shortcomings, the 2018 ESC/EACTS Guidelines on myo-
cardial revascularization gave TTFM for intraoperative graft as-
sessment a class-IIa recommendation [79].
Limitations
As with any meta-analysis of observational studies, limitations
related to the observational nature of studies cannot be over-
come. One important challenge is that, currently, no consensus
exists on uniform TTFM cut-off values to classify grafts as ‘abnor-
mal’ or requiring revision. This could have caused the relatively
increased heterogeneity of the results. To allow a conservative es-
timate, we have analysed the data using random-effects models,
as recommended for meta-analyses on observational studies [80].
However, considering the heterogeneity of study definitions and
end points in papers reporting the association between TTFM
and graft patency and clinical outcomes, no meta-analysis was
performed on these outcomes, as it was considered to be in-
appropriate to pool heterogeneous results.
CONCLUSION
TTFM has potential to further improve the quality of CABG pro-
cedures and could improve clinical outcomes for patients.
In 4.3% of patients undergoing CABG, there was a need to revise
grafts after TTFM assessment. However, only 25% of grafts, classi-
fied as abnormal based on TTFM values, were revised, suggesting
that the use of TTFM can be further optimized. Indeed, reaching
consensus on TTFM remains difficult due to the substantial het-
erogeneity in published TTFM data, which could be related to
varying haemodynamics during assessment, the location of the
TTFM probe (e.g. proximal or distal on the graft), varying cut-off
values for revision and the use of different graft types (e.g. intern-
al thoracic artery, saphenous vein or radial artery) on unique cor-
onary arteries with varying degrees of stenosis. Future studies
should focus on determining the optimal use of TTFM and there-
by further guiding surgeons to improve outcomes after CABG.
A multicentre study with standardized TTFM use and definitions
on graft revision may provide more insights into the optimal use
of this technique.
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